(Reuters) - Analysts had expected earnings before interest and taxes
, excluding its pharma unit, which will be sold, and incidentals, to fall 5.3 percent to 179 million, according to the average forecast of six analysts in a Reuters poll.
Read more at Reuters.com Market News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment